- 询价
- MedChemExpress(MCE)
- 美国
- HY-143493
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- CAS号：
2411584-06-8
- 规格：
询盘
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Influenza virus-IN-2
CAS No. : 2411584-06-8
MCE 国际站：Influenza virus-IN-2
产品活性：Influenza virus-IN-2 (compound 19) 是一种有效的 流感病毒 抑制剂，EC50 为 2.58 µM, CC< sub>50 的 150.85 µM。Influenza virus-IN-2 对 PAN 核酸内切酶具有浓度依赖性抑制活性，EC50 为 489.39 nM。Influenza virus-IN-2 显示出抗甲型流感病毒活性。
研究领域：Anti-infection
作用靶点：Influenza Virus
相关产品：Acetylcysteine | Tunicamycin | U0126-EtOH | Curcumin | Camptothecin | Vadimezan | Indomethacin | Molnupiravir | Aprotinin | Rifampicin | Baicalein | Oseltamivir acid | Geldanamycin | AEBSF hydrochloride | Spermine | α-Vitamin E | AG-1478 | HA Peptide | Chlorogenic acid | YM-201636 | Tofacitinib citrate | Favipiravir | Harringtonine | Baloxavir | Trimethoprim | SC75741 | 6-Diazo-5-oxo-L-nor-Leucine | GSK 650394 | Isoliquiritigenin
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验and production of vaccine. Since influenza is caused by a zoonotic virus it is necessary to do surveillance in the reservoir species (aquatic waterfowls), intermediate hosts (quails, pigs), and in affected mammals including humans. Two of the hemagglutinin (HA
Influenza Viruses: An Introduction
We provide a brief introduction into the genome organization, life cycle, pathogenicity, and host range of influenza A viruses. We also briefly summarize influenza pandemics and currently available measures to control influenza virus
Reverse Genetics of Influenza Viruses
, and transmissibility. Moreover, this technology is now being used to generate approved influenza virus vaccines and develop novel vaccines to combat seasonal and (future) pandemic influenza viruses. Several variations of the original system have been established
技术资料暂无技术资料 索取技术资料
